Trials / Completed
CompletedNCT05925114
Safety and Efficacy Study of S-309309 in Obese Adults
A Phase 2, Multicenter, Randomized, Double-blind, Dose-ranging, Placebo-controlled Study to Assess the Safety and Efficacy of S-309309 in Obese Adults
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 365 (actual)
- Sponsor
- Shionogi · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to understand the efficacy of S-309309 on the body weight of obese adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | S-309309 | Administered as oral capsules |
| DRUG | Placebo | Administered as an oral capsule that looks identical to S-309309 capsule |
Timeline
- Start date
- 2023-06-21
- Primary completion
- 2024-04-15
- Completion
- 2024-05-17
- First posted
- 2023-06-29
- Last updated
- 2025-04-16
Locations
49 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05925114. Inclusion in this directory is not an endorsement.